At the 6-week mark, the Pulsed Electromagnetic Fie
Post# of 8682
(Total Views: 169)
Posted On: 09/29/2025 9:25:53 PM
Re: Bielionaire #8670
At the 6-week mark, the Pulsed Electromagnetic Field (PEMF) therapy group experienced a significantly larger reduction in the Numeric Pain Rating Scale (NPRS) score compared to the sham device (placebo) group.
The key phrase here is "significantly greater change", which is supported by the P-value (P = .02).
Key Components Explained
1. Change in Average NPRS from Baseline
* NPRS (Numeric Pain Rating Scale): This is a common tool where patients rate their pain level, typically on a scale of 0 (no pain) to 10 (worst possible pain).
* Change from Baseline: This refers to the difference between the pain score at the start of the study (baseline) and the score after 6 weeks. A greater reduction (a more negative change) is a desired outcome, indicating improved pain relief.
2. PEMF Therapy Group vs. Sham Device Group
* PEMF Therapy Group: Received the actual therapeutic intervention (Pulsed Electromagnetic Fields).
* Sham Device Group: Received a placebo or inert device designed to look and feel like the active treatment but without the active therapeutic effect. This group helps to account for the placebo effect.
3. Statistical Significance (P = .02)
* P-value: In this context, P = .02 means that there is only a 2% probability that the observed difference in pain reduction between the PEMF group and the sham group occurred purely by random chance, assuming the PEMF therapy actually has no effect.
* Interpretation: Because the P-value is less than the standard threshold (usually P < .05), the difference is considered statistically significant. This provides strong evidence that the PEMF therapy itself was genuinely more effective at reducing pain than the placebo effect alone after 6 weeks.
In Simple Terms
The study suggests that PEMF therapy worked better than a placebo for pain relief after 6 weeks, and this finding is highly unlikely to be a fluke.
The key phrase here is "significantly greater change", which is supported by the P-value (P = .02).
Key Components Explained
1. Change in Average NPRS from Baseline
* NPRS (Numeric Pain Rating Scale): This is a common tool where patients rate their pain level, typically on a scale of 0 (no pain) to 10 (worst possible pain).
* Change from Baseline: This refers to the difference between the pain score at the start of the study (baseline) and the score after 6 weeks. A greater reduction (a more negative change) is a desired outcome, indicating improved pain relief.
2. PEMF Therapy Group vs. Sham Device Group
* PEMF Therapy Group: Received the actual therapeutic intervention (Pulsed Electromagnetic Fields).
* Sham Device Group: Received a placebo or inert device designed to look and feel like the active treatment but without the active therapeutic effect. This group helps to account for the placebo effect.
3. Statistical Significance (P = .02)
* P-value: In this context, P = .02 means that there is only a 2% probability that the observed difference in pain reduction between the PEMF group and the sham group occurred purely by random chance, assuming the PEMF therapy actually has no effect.
* Interpretation: Because the P-value is less than the standard threshold (usually P < .05), the difference is considered statistically significant. This provides strong evidence that the PEMF therapy itself was genuinely more effective at reducing pain than the placebo effect alone after 6 weeks.
In Simple Terms
The study suggests that PEMF therapy worked better than a placebo for pain relief after 6 weeks, and this finding is highly unlikely to be a fluke.
(1)
(0)